Protein Qualification & Validation
Ensure that your proteins and antibodies are ready for use with qualification and validation performed by the experienced scientists at antibodies-online and Rockland Immunochemicals, Inc. (Rockland). We work with you to develop and execute an effective protein and antibody validation and/or qualification plan that is informative and adheres to the most rigorous scientific standards.
Our Validation & Qualification Capabilities
We have a comprehensive suite of assays that we can leverage for ensuring the purity, activity, and integrity of your reagent, including:
- SDS-PAGE
- Western blotting
- Dot blot
- ELISA
- BCA Electrophoretic mobility shift assay (EMSA)
- Ligand binding assays
- Biotin detection
- Endotoxin detection
- Mycoplasma detection
- Precipitin test
- And more!
Certain assays can be performed using FDA-approved reagents, and every project comes with detailed reporting. Learn more about our complete capabilities and how we can support your project by contacting us.
Start Your Project
Our Service Partner: Rockland
Our Service Partner: Rockland
Benefit from expertise over two generations of scientific advances. Rockland enabling biomolecule detection, characterization and analysis since 1962. 60,000 square feet manufacturing facility produce high-quality antibodies, reagents and custom services for your next project
Benefit from expertise over two generations of scientific advances. Rockland enabling biomolecule detection, characterization and analysis since 1962. 60,000 square feet manufacturing facility produce high-quality antibodies, reagents and custom services for your next project
Adhering to the Highest Standards
Driven by science and committed to quality, our protein and antibody validation and qualification team is proud to deliver the highest quality work for both external customers and antibodies-online's own products. We operate with the highest levels of integrity—it’s what our customers and your customers rely on—and we fully communicate what the assays tell us, whether it’s good news or not.
